Abt M, de Jonge J, Laue M, Wolff T. Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content. (2011). Vaccine. 29(32):5153-62.

Anhlan D, Grundmann N, Makalowski W, Ludwig S, Scholtissek C. Origin of the 1918 pandemic H1N1 influenza A virus as studied by codon usage patterns and phylogenetic analysis. (2011). RNA 17(1):64-73.

Bahgat MM, Błazejewska P, Schughart K. Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection. (2011). Virol J. 8:27.

Bel M, Ocaña-Macchi M, Liniger M, McCullough KC, Matrosovich M, Summerfield A. Efficient sensing of avian influenza viruses by porcine plasmacytoid dendritic cells. (2011). Viruses. 3(4):312-30.

Blazejewska P, Koscinski L, Viegas N, Anhlan D, Ludwig S, Schughart K. Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factors. (2011). Virology. 412(1):36-45.

Bogs J, Kalthoff D, Veits J, Pavlova S, Schwemmle M, Mänz B, Mettenleiter TC, Stech J. Reversion of PB2-627E to -627K during replication of an H5N1 Clade 2.2 virus in mammalian hosts depends on the origin of the nucleoprotein. (2011). J Virol. 85(20):10691-8.

Bortz E, Westera L, Maamary J, Steel J, Albrecht RA, Manicassamy B, Chase G, Martínez- Sobrido L, Schwemmle M, García-Sastre A. Host- and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins. (2011). MBio. 16;2(4).

Chase G, Wunderlich K, Reuther P, Schwemmle M. Identification of influenza virus inhibitors which disrupt of viral polymerase protein-protein interactions. (2011). Methods. 55(2):188-91.

Chase GP, Rameix-Welti MA, Zvirbliene A, Zvirblis G, Götz V, Wolff T, Naffakh N, Schwemmle M. Influenza Virus Ribonucleoprotein Complexes Gain Preferential Access to Cellular Export Machinery through Chromatin Targeting. (2011). PLoS Pathog. 7(9):e1002187.

Deng Q, Wang D, Xiang X, Gao X, Hardwidge PR, Kaushik R, Wolff T, Chakravarty S, Li F. Nuclear localization of influenza B polymerase proteins and their binary complexes. (2011). Virus Res. 156(1-2):49-53.

Deng Q, Wang D, Xiang X, Gao X, Hardwidge PR, Kaushik RS, Wolff T, Chakravarty S, Li F. Application of a split luciferase complementation assay for the detection of viral proteinprotein interactions. (2011). J Virol Methods. 176(1-2):108-11.

Dimitrakopoulou K, Tsimpouris C, Papadopoulos G, Pommerenke C, Wilk E, Sgarbas KN, Schughart K, Bezerianos A. Dynamic gene network reconstruction from gene expression data in mice after influenza A (H1N1) infection. (2011). J Clin Bioinforma. Oct 21;1:27.

Droebner K, Pleschka S, Ludwig S, Planz O. Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo. (2011). Antiviral Res. 92(2):195-203.

Dudek SE, Wixler L, Nordhoff C, Nordmann A, Anhlan D, Wixler V, Ludwig S. The influenza virus PB1-F2 protein has interferon antagonistic activity. (2011). Biol Chem. 392(12):1135- 44.

Gao S, von der Malsburg A, Dick A, Faelber K, Schröder GF, Haller O, Kochs G, Daumke O. Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function. (2011). Immunity. 35(4):514-25.

Ge X, Rameix-Welti MA, Gault E, Chase G, dos Santos Afonso E, Picard D, Schwemmle M, Naffakh N. Influenza virus infection induces the nuclear relocalization of the Hsp90 cochaperone p23 and inhibits the glucocorticoid receptor response. (2011). PLoS One. 6(8):e23368.

Haasbach E, Droebner K, Vogel AB, Planz O. Low-Dose Interferon Type I Treatment Is Effective Against H5N1 and Swine-Origin H1N1 Influenza A Viruses In Vitro and In Vivo. (2011). J Interferon Cytokine Res. 31(6):515-25.

Haasbach E, Pauli EK, Spranger R, Mitzner D, Schubert U, Kircheis R, Planz O. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses. (2011). Antiviral Res. 91(3):304-13.

Herold S. Pathogenesis, symptoms and treatment of virus influenza. (2011). Pharm Unserer Zeit. 40(2):115-9. Review. German.

Hrincius ER, Dierkes R, Anhlan D, Wixler V, Ludwig S, Ehrhardt C. Phosphatidylinositol-3- kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptor Rig-I to promote efficient type I interferon production. (2011). Cell Microbiol. 13(12):1907-19.

Hundt B, Mölle N, Stefaniak S, Dürrwald R, Weyand J. Large pilot scale cultivation process study of adherent MDBK cells for porcine Influenza A virus propagation using a novel disposable stirred-tank bioreactor. (2011). BMC Proc. 5Suppl 8:P128.

Kirchmair J, Rollinger JM, Liedl KR, Seidel N, Krumbholz A, Schmidtke M. Novel neuraminidase inhibitors: identification, biological evaluation and investigations of the binding mode. (2011). Future Med Chem. 3(4):437-50.

Klenk HD, Garten W, Matrosovich M. Molecular mechanisms of interspecies transmission and pathogenicity of influenza viruses: Lessons from the 2009 pandemic. (2011). Bioessays. 33(3):180-8.

Krawitz C, Abu Mraheil M, Stein M, Imirzalioglu C, Domann E, Pleschka S, Hain T. Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses. (2011). BMC Complement Altern Med. 11(1):16.

Krumbholz A, Philipps A, Oehring H, Schwarzer K, Eitner A, Wutzler P, Zell R. 2010. Current knowledge on PB1-F2 of influenza A viruses. (2011). Med Microbiol Immunol. 200(2):69-75.

Liu S, Li R, Zhang R, Chan CC, Xi B, Zhu Z, Yang J, Poon VK, Zhou J, Chen M, Münch J, Kirchhoff F, Pleschka S, Haarmann T, Dietrich U, Pan C, Du L, Jiang S, Zheng B. CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry. (2011). Eur J Pharmacol. 660(2-3):460-7.

Ludwig S. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections. (2011). Biol Chem. 392(10):837-47.

Mänz, B., V. Götz, K. Wunderlich, J. Eisel, J. Kirchmair, J. Stech, O. Stech, G. Chase, R. Frank, and M. Schwemmle. Disruption of the viral polymerase complex assembly as a novel approach to attenuate influenza a virus. (2011). J Biol Chem 286:8414-24.

Muhammad S, Haasbach E, Kotchourko M, Strigli A, Krenz A, Ridder DA, Vogel AB, Marti HH, Al-Abed Y, Planz O, Schwaninger M. Influenza virus infection aggravates stroke outcome. (2011). Stroke. 42(3):783-91.

Penski N, Härtle S, Rubbenstroth D, Krohmann C, Ruggli N, Schusser B, Pfann M, Reuter A, Gohrbandt S, Hundt J, Veits J, Breithaupt A, Kochs G, Stech J, Summerfield A, Vahlenkamp T, Kaspers B, Staeheli P. Highly pathogenic avian influenza viruses do not inhibit interferon synthesis in infected chickens but can override the interferon-induced antiviral state. (2011). J Virol. 85(15):7730-41.

Pinto R, Herold S, Cakarova L, Hoegner K, Lohmeyer J, Planz O, Pleschka S. Inhibition of influenza virus-induced NF-kappaB and Raf-MEK-ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo. (2011). Antiviral Res. 92(1):45-56.

Punyadarsaniya D, Liang CH, Winter C, Petersen H, Rautenschlein S, Hennig-Pauka I, Schwegmann-Wessels C, Wu CY, Wong CH, Herrler G. Infection of differentiated porcine airway epithelial cells by influenza virus: differential susceptibility to infection by porcine and avian viruses. (2011). PLoS One. 6(12):e28429.

Reuther P, Mänz B, Brunotte L, Schwemmle M, Wunderlich K. Targeting of the influenza A virus polymerase PB1-PB2 interface indicates strain-specific assembly differences. (2011). J Virol. 85(24):13298-309.

Robb, N. C., G. Chase, K. Bier, F. T. Vreede, P. C. Shaw, N. Naffakh, M. Schwemmle, and E. Fodor. The Influenza A NS1 Protein Interacts with the Nucleoprotein of Viral Ribonucleoprotein Complexes. (2011). J Virol. 85(10): 5228-31.

Schusser B, Reuter A, von der Malsburg A, Penski N, Weigend S, Kaspers B, Staeheli P, Härtle S. Mx is dispensable for interferon-mediated resistance of chicken cells againstinfluenza A virus. (2011). J Virol. 85(16):8307-15.

Sipo I, Knauf M, Fechner H, Poller W, Planz O, Kurth R, Norley S. Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV). (2011). Vaccine. 29(8):1690-9.

Skarlas T, Zevgiti S, Droebner K, Panou-Pomonis E, Planz O, Sakarellos-Daitsiotis M. Influenza virus H5N1 hemagglutinin (HA) T-cell epitope conjugates: design, synthesis and immunogenicity. (2011). J Pept Sci. 17(3):226-32.

Stech J, Garn H, Herwig A, Stech O, Dauber B, Wolff T, Mettenleiter TC, Klenk HD. Influenza B virus with modified hemagglutinin cleavage site as a novel attenuated live vaccine. (2011). J Infect Dis. 204(10):1483-90.

Viemann, D., M. Schmolke, A. Lueken, Y. Boergeling, J. Friesenhagen, H. Wittkowski, S. Ludwig, and J. Roth.H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response. (2011). J. Immunol. 186: 164-173.

von der Malsburg A, Abutbul-Ionita I, Haller O, Kochs G, Danino D. Stalk domain of the dynamin-like MxA GTPase protein mediates membrane binding and liposome tubulation via the unstructured L4 loop. (2011). J Biol Chem. 286(43):37858-65.

Wunderlich K, Juozapaitis M, Ranadheera C, Kessler U, Martin A, Eisel J, Beutling U, Frank R, Schwemmle M. Identification of high-affinity PB1-derived peptides with enhanced affinity to the PA protein of influenza A virus polymerase. (2011). Antimicrob Agents Chemother. 55(2):696-702.

Zhirnov OP, Matrosovich TY, Matrosovich MN, Klenk HD. Aprotinin, a protease inhibitor, suppresses proteolytic activation of pandemic H1N1v influenza virus. (2011). Antivir Chem Chemother. 21(4):169-74. Erratum in: (2011). Antivir Chem Chemother. 21(6):245.

Zimmermann P, Mänz B, Haller O, Schwemmle M, Kochs G. The viral nucleoprotein determines Mx sensitivity of influenza A viruses. (2011). J Virol. 85(16):8133-40.